Dr. Ann M. Gillenwater
Claim this profileM D Anderson Cancer Center
Studies Mouth cancer
Studies Squamous Cell Carcinoma
9 reported clinical trials
23 drugs studied
Area of expertise
1Mouth Cancer
2Squamous Cell Carcinoma
Stage III
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Ann M. Gillenwater is currently running
Multispectral + High-Resolution Microendoscopy
for Oral Cancer
This clinical trial studies wide-field and high resolution in vivo imaging in visualizing lesions in patients with abnormal or uncontrolled oral cell growth (neoplasia) undergoing surgery. Diagnostic procedures, such as wide-field and high resolution in vivo imaging, are devices that let researchers look at a wide area of the lining of the mouth by shining different colors inside the mouth and taking pictures and this may help doctors to decide if a mouth lesion has a high risk of being pre-cancerous or cancerous.
Recruiting1 award Phase < 1
ASP-1929 + Pembrolizumab
for Head and Neck Cancer
The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy (PIT) in combination with pembrolizumab works to treat recurrent squamous cell cancer of the head and neck (HNSCC) with no distant metastases. It will also learn about the safety of ASP-1929 PIT in combination with pembrolizumab. Researchers will compare ASP-1929 PIT in combination with pembrolizumab to pembrolizumab alone or pembrolizumab plus chemotherapy (carboplatin or cisplatin, plus 5-fluorouracil or paclitaxel or docetaxel) according to physician's choice (control arm). The overall primary study hypothesis being tested is whether ASP-1929 PIT plus pembrolizumab combination treatment improves the overall survival (OS) of the population defined by the inclusion/exclusion criteria over the control arm.
Recruiting2 awards Phase 36 criteria
More about Ann M. Gillenwater
Clinical Trial Related14 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ann M. Gillenwater has experience with
- High-Resolution Microendoscopy
- Fluorescence Imaging
- Pembrolizumab
- ASP-1929 Photoimmunotherapy
- High Resolution Microendoscope (HRME)
- Optical Mapping Scope
Breakdown of trials Ann M. Gillenwater has run
Mouth cancer
Squamous Cell Carcinoma
Skin Cancer
Oral Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ann M. Gillenwater specialize in?
Ann M. Gillenwater focuses on Mouth cancer and Squamous Cell Carcinoma. In particular, much of their work with Mouth cancer has involved treating patients, or patients who are undergoing treatment.
Is Ann M. Gillenwater currently recruiting for clinical trials?
Yes, Ann M. Gillenwater is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Ann M. Gillenwater has studied deeply?
Yes, Ann M. Gillenwater has studied treatments such as High-Resolution Microendoscopy, Fluorescence Imaging, Pembrolizumab.
What is the best way to schedule an appointment with Ann M. Gillenwater?
Apply for one of the trials that Ann M. Gillenwater is conducting.
What is the office address of Ann M. Gillenwater?
The office of Ann M. Gillenwater is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.